Pitt Ophthalmology Research retweeted
Rob Lin, PhD, CEO, Avista Therapeutics, says scAAVenger platform provides a cell-specific toolkit for gene therapy development, resulting in higher expression and lower inflammation with lower gene therapy doses. Avista management includes Sahel, Sieving, Byrne.
Great story featuring Drs. Sahel, Martel, and Smith
upmcphysicianresources.com/p…
Pitt Ophthalmology Research retweeted
Si Chen, Kira Lathrop, Takaaki Kuwajima and Jeffrey Gross dissect the role of Jak/Stat signalling in modulating crosstalk between macrophages/microglia and retinal ganglion cells to regulate RGC survival after severe optic nerve injury
journals.biologists.com/dev/…
Congratulations Dr. Sahel!
falling-walls.com/press-rele…
New review of Epigenetic Regulations of Retinal Development from Jeff Gross and Issam Al Diri
epigeneticsandchromatin.biom…
Exciting news for Ophthalmology!
pittwire.pitt.edu/news/fda-a…
New!! The St. Leger Lab shows that VEGF-A immune cells disrupts corneal nerves leading to blinding disease during HSV-1 infection. @Immunity Check it out:authors.elsevier.com/a/1c5K5…
Postdoctoral Fellow in the epigenetic regulation of retinal development
NIH-funded postdoctoral position is available in the laboratory of Dr. Jeff Gross (jeffgrosslab.org) in the Department of Ophthalmology at Pitt
Interested candidates send info to [email protected]
A new Review article by Jeff Gross on eye evolution: Evolution and development of complex eyes: a celebration of diversity
dev.biologists.org/content/1…
New work from the Byrne Lab just posted on bioRxiv! scAAVengr: Single-cell transcriptome-based quantification of engineered AAVs in non-human primate retina: biorxiv.org/content/10.1101/…
@ByrneLabScience
Check out the @PittMedMag article featuring our very own Ian Sigal!
pittmed.health.pitt.edu/stor…
Happy 60th Anniversary to @RPB_org and their President, Dr. Brian Hofland
Consider making an anniversary donation to the RPB via the attached link:
rpbusa.org/rpb/support/donat…
Incredibly proud of the Funderburgh Lab
The Funderburgh Lab published in Stem Cells Translational Medicine today! Get your read on!
rdcu.be/bJEqY
Simply Amazing!
UPMC physicians first to implant next regeneration wireless retinal device in clinical trial to restore partial sight to patients with advanced age-related macular degeneration, which leads to permanent blindness and has no cure. upmc.me/3a71iCz






